{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17(11)"],"submitter":["Hegi ME"],"journal":["Neuro-oncology"],"pagination":["1425-7"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4648310"],"repository":["biostudies-literature"],"pubmed_title":["Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?"],"pmcid":["PMC4648310"],"pubmed_authors":["Stupp R","Hegi ME"],"additional_accession":[]},"is_claimable":false,"name":"Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?","description":null,"dates":{"release":"2015-01-01T00:00:00Z","publication":"2015 Nov","modification":"2025-04-26T19:25:26.418Z","creation":"2025-04-06T16:04:49.369Z"},"accession":"S-EPMC4648310","cross_references":{"pubmed":["26374690"],"doi":["10.1093/neuonc/nov198"]}}